Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 9268906

A simple image display application for windows.

G R Conrad
View original source ↗Export metadata ↓

Abstract

The purpose of this project was to develop a simple application for displaying low-to-moderate resolution digital images under the Windows operating environment. The display of scintigraphic images was of special interest, and for this reason the program was designed to show sequences of images and to account for broad ranges of pixel values. In order to function under a variety of Windows versions, the program was developed using the 16-bit Microsoft C +2 compiler and targeted for Windows 3.1 enhanced. It was tested with Trionix images for nuclear medicine and Siemens for computed tomography (CT) and magnetic resonance (MR). The resulting application, called SID, successfully read Magnetom, Somatom, Trionix, and Interfile images of dimension 512 or less on Intel-based Windows PCs with 256 color SVGA-compatible (Super Video Graphics Adapters) video hardware. Early applications of the program included remote monitoring of image studies, resident review of teaching cases, review of research images, and preparation of educational materials. This article describes the features, operation, and potential applications of SID.

Explore related subjects

ComputersData DisplayDiagnostic ImagingHumansImage EnhancementRadiology Information SystemsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G R Conrad. 1997. A simple image display application for windows.. https://doi.org/10.1007/bf03168598

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Avatars in space.

Explore the source record for details and available documents.

Computers↗
PubMed2000

Structure-based inhibitor design.

Time and costs associated with the discovery of new drugs have been significantly reduced by enzyme structure-based approaches to the discovery of new chemotherapeutic agents. However, fundamental components of the overall approach continue to rely on technologies which, by their nature, involve relatively random processes (i.e., combinatorial chemistry and high-throughput screening). Thus, the efficiency of the drug discovery process potentially could be further improved through better use of structural information. In this regard, three-dimensional structures of enzymes are now being solved at high resolution and/or in conformations that provide data that should be more useful for inhibitor design or discovery. Scientists are beginning to appreciate the importance of water as a possible competitor of inhibitors for binding to target enzymes. New computational algorithms are improving the efficiency of identifying flexible inhibitors from among the large numbers of compounds in chemical databases. Also, tools of molecular genetics together with structures of target enzymes are likely to be used more frequently in dealing with the development of resistance to novel chemotherapeutic agents. Instead of detailing success stories in structure-based drug discovery, the following article considers how future efforts to discover or design new drugs may increasingly rely on information about molecular targets and less on data acquired via approaches involving random methodologies.

Computers↗